Loading organizations...
§ Private Profile · Office 152 Unit 5, Area 1/1 399-405 Oxford Street, London, W1C 2BU, United Kingdom
Techspert is a technology company.
Techspert delivers an AI-driven primary research platform, connecting professionals with subject matter experts in healthcare and life sciences. It leverages proprietary machine learning and advanced technology to identify specialists from a vast global network. The platform offers automated call analysis, data capture, and an AI assistant, streamlining insight generation for efficient research.
Co-founded in 2016 by David Holden and Graham Mills, Techspert originated from Holden's biotechnology background and his patent attorney work. His experience at a diagnostics startup revealed a critical need for efficient access to specialized expert insights during market research, inspiring their vision to transform global knowledge transfer.
Techspert serves clients across healthcare and life sciences, including consultancies, marketing agencies, and pharmaceutical companies. It empowers these organizations to conduct efficient research by connecting them with relevant professionals. The company's vision is to continually advance primary research, delivering precision and efficiency in expert sourcing for critical decisions.
Techspert has raised $18.3M across 3 funding rounds.
Techspert has raised $18.3M in total across 3 funding rounds.
Techspert has raised $18.3M in total across 3 funding rounds.
Techspert's investors include Mark Nunny, Mike Adam, Nauta Capital, Plug & Play Ventures, John Spearman, Zack Feather, Cambridge Angels, Adrian Lloyd, Simon Thorpe, ACF Investors.
Techspert is a UK-based technology company founded in 2015-2016, specializing as the leading primary research platform and expert network for healthcare and life sciences, including medical devices, pharmaceuticals, biotechnology, and diagnostics.[3][4][5] It connects clients seeking insights—such as biotech firms, market researchers, and consultancies—with hard-to-reach subject matter experts through AI-driven search technology, offering services like expert calls, surveys, focus groups, data reviews, and automated response capture via a project portal.[3][4][5][6] Serving quantitative and qualitative research needs, Techspert solves the challenge of accessing precise, fresh expertise beyond traditional databases, boasting a network of 25-280 million contactable experts (1 in 4 consulting for the first time), 70% customer acceptance rates (double industry average), and tools like a "Feasibility Calculator."[3][5][6] With $18.3 million in revenue, 75 employees, a US office in Houston, and funding totaling over £13.55 million plus venture debt, it demonstrates strong growth momentum through venture backing and expansions.[2][3]
Techspert emerged in 2015 in Cambridge, UK, initially as Biotechspert with a broader life sciences focus, pivoting successfully to expert calls and raising its first £1 million from angels in December 2018.[3][4] Co-founders Dave Holden (CEO, with a Master's in Biochemistry from Oxford and Bioscience Enterprise from Cambridge, background in biotechnology) and Chris (focused on funding and growth) started after struggling to access novel industry experts amid generic pools and overused panels in an interconnected world.[3][4] They harnessed AI and data science from Cambridge specialists to build proprietary search tech scanning 150 million profiles—200 times larger than competitors like GLG—in minutes, alongside a custom project management platform.[3][4] Key milestones include a £3.75 million Series A in 2020 from Nauta Capital, £8.8 million ($12 million) in 2021 from BGF and Nauta, venture debt in 2023, opening a US office in Houston in 2021, and growing from 42 employees in 2021.[3][4]
Techspert rides the AI-driven transformation of primary research and expert networks, addressing inefficiencies in knowledge access amid exploding healthcare data and demand for real-time, niche insights in life sciences.[3][4][6] Timing aligns with post-2020 venture surges, biotech booms, and AI adoption, amplified by its 2018 pivot and expansions during funding waves from Nauta, BGF, and others.[3] Market forces favoring it include the limitations of human-led searches (slower, shallower pools) versus Techspert's scalable AI, enabling deeper penetration into therapeutics, product development, and innovation scouting—e.g., for launches or feasibility studies.[5][6] It influences the ecosystem by raising industry bars on precision (e.g., via unique experts and automation), competing with giants like Guidepoint or GLG, and fostering global knowledge exchange through its hub, while expanding to the US amid growing cross-border research needs.[3][4][5]
Techspert is poised to dominate AI-augmented expert networks in healthcare, leveraging its tech edge to scale beyond current 75 employees and $18.3 million revenue toward global leadership.[2][3] Upcoming trends like advanced AI for predictive analytics, deeper quant integration, and expansion into adjacent sectors (e.g., broader biotech or medtech) will shape its path, building on recent tools and debt funding for R&D.[3][5][6] Its influence may evolve by disrupting incumbents, powering more automated research pipelines, and attracting acquirers or larger rounds as primary research demand surges with personalized medicine and regulatory complexities—cementing its role as the go-to for insights no one else can unlock.[3][4][6]
Techspert has raised $18.3M across 3 funding rounds. Most recently, it raised $12.0M Series B in October 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 1, 2021 | $12M Series B | Mark Nunny | Mike Adam, Nauta Capital | Announced |
| Feb 1, 2020 | $5M Series A | Nauta Capital | Plug & Play Ventures, John Spearman, Zack Feather, Cambridge Angels | Announced |
| Dec 11, 2018 | $1.3M Venture Round | — | Adrian Lloyd, John Spearman, Simon Thorpe, ACF Investors | Announced |